Biography

An internationally recognized expert on retinal disorders, Dr. Miller is credited with co-developing verteporfin photodynamic therapy (PDT), the first pharmacologic treatment for retinal disease, and co-discovering the role of vascular endothelial growth factors (VEGF) in eye disease. Her research also demonstrated the therapeutic potential of VEGF inhibitors, which are currently used to treat eye diseases such as age-related macular degeneration (AMD) and diabetic retinopathy. She has authored more than 280 peer-reviewed papers and 60 book chapters or review articles, and is a named inventor on ten US patents and five Canadian patents. Additionally, she is a co-editor of the 3rd edition of Albert and Jakobiec’s Principles and Practice of Ophthalmology, an editorial board member of the journal Ophthalmology. Among Dr. Miller’s multiple honors, she is a laureate of the 2014 António Champalimaud Vision Award, the highest distinction in ophthalmology and visual science, and is the 2015 recipient of the Mildred Weisenfeld Award for Excellence in Ophthalmology. In 2018, she became the first woman awarded the Charles L. Schepens Award from AAO. Recently, Dr. Miller was awarded the 2018 Lucien Howe Medal from the American Ophthalmological Society, and the 2018 Gertrude D. Pyron Award from American Society of Retinal Specialists.